IAM
MRNA icon

Impala Asset Management’s Moderna MRNA Stock Holding History

Impala Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,082
Closed -$703K – 32
2022
Q1 		$703K Sell
4,082
-818
-17% -$138K 0.06% 38
2021
Q4 		$1.25M Sell
4,900
-583
-11% -$170K 0.1% 45
2021
Q3 		$2.11M Buy
+5,483
New +$2.02M 0.15% 50

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Impala Asset Management's MRNA Position: Q2 2022 in Review

Impala Asset Management sold out of Moderna (MRNA) in Q2 2022, closing a stake of 4,082 shares — an estimated $703K sold.

Impala Asset Management first reported a position in MRNA in Q3 2021 and held it in 3 quarters. The position peaked at $2.11M in Q3 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Impala Asset Management reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Impala Asset Management sold 4,082 Moderna shares in Q2 2022, an estimated $703K.
  • Impala Asset Management first reported a position in Moderna in Q3 2021 and held it in 3 quarters.
  • Impala Asset Management's Moderna position peaked at $2.11M in Q3 2021.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Impala Asset Management's 13F filing for Q2 2022, filed 10 Aug 2022.